Clinical Trial Update: Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity

View source ↗

Summary

This clinical trial update reports the safety and efficacy of solifenacin in men with overactive bladder and detrusor underactivity; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Underactivity
• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: University of L'Aquila | Conditions: Overactive Bladder, Detrusor Underactivity | Status: COMPLETED